title: [Treatment of pancreatic fistulas with somatostatin].
abstract: Four cases of pancreatic fistula were treated with somatostatin. Two cases occurred after caudal pancreatectomy and the other 2 after duodenopancreatectomy. Somatostatin rapidly reduced fistula flow by 50% 48 hours after treatment. The shorter hospital stay and reduced morbidity underline the importance of somatostatin in the treatment of pancreatic fistulae.
authors.affiliation: Service de Chirurgie Générale et Digestive, Hôpital de la Conception, Marseille.
authors.forename: B
authors.initials: B
authors.lastname: Berthet
authors.forename: P
authors.initials: P
authors.lastname: Delaitre
authors.forename: S
authors.initials: S
authors.lastname: Berdah
authors.forename: R
authors.initials: R
authors.lastname: Assadourian
mesh_terms: D000328:Adult; D000368:Aged; D000744:Anemia, Hemolytic, Autoimmune / Q000601:surgery; D002769:Cholelithiasis / Q000601:surgery; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010180:Pancreatectomy / Q000009:adverse effects*; D010185:Pancreatic Fistula / Q000188:drug therapy* / Q000209:etiology; D010190:Pancreatic Neoplasms / Q000601:surgery; D016577:Pancreaticoduodenectomy / Q000009:adverse effects*; D011183:Postoperative Complications; D013004:Somatostatin / Q000008:administration & dosage / Q000627:therapeutic use*; D013274:Stomach Neoplasms / Q000601:surgery
chemical_list: D013004:Somatostatin
vernacular_title: Traitement des fistules pancréatiques par la somatostatine.